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ABSTRACT
Background
Recently, a global commitment has been made to expand access to antiretrovirals (ARVs) in
the developing world. However, in many resource-constrained countries the number of
individuals infected with HIV in need of treatment will far exceed the supply of ARVs, and only a
limited number of health-care facilities (HCFs) will be available for ARV distribution. Deciding
how to allocate the limited supply of ARVs among HCFs will be extremely difficult. Resource
allocation decisions can be made on the basis of many epidemiological, ethical, or preferential
treatment priority criteria.
Methods and Findings
Here we use operations research techniques, and we show how to determine the optimal
strategy for allocating ARVs among HCFs in order to satisfy the equitable criterion that each
individual infected with HIV has an equal chance of receiving ARVs. We present a novel spatial
mathematical model that includes heterogeneity in treatment accessibility. We show how to
use our theoretical framework, in conjunction with an equity objective function, to determine
an optimal equitable allocation strategy (OEAS) for ARVs in resource-constrained regions. Our
equity objective function enables us to apply the egalitarian principle of equity with respect to
access to health care. We use data from the detailed ARV rollout plan designed by the
government of South Africa to determine an OEAS for the province of KwaZulu–Natal. We
determine the OEAS for KwaZulu–Natal, and we then compare this OEAS with two other ARV
allocation strategies: (i) allocating ARVs only to Durban (the largest urban city in KwaZulu–Natal
province) and (ii) allocating ARVs equally to all available HCFs. In addition, we compare the
OEAS to the current allocation plan of the South African government (which is based upon
allocating ARVs to 17 HCFs). We show that our OEAS significantly improves equity in treatment
accessibility in comparison with these three ARV allocation strategies. We also quantify how the
size of the catchment region surrounding each HCF, and the number of HCFs utilized for ARV
distribution, alters the OEAS and the probability of achieving equity in treatment accessibility.
We calculate that in order to achieve the greatest degree of treatment equity for individuals
with HIV in KwaZulu–Natal, the ARVs should be allocated to 54 HCFs and each HCF should
serve a catchment region of 40 to 60 km.
Conclusion
Our OEAS would substantially improve equality in treatment accessibility in comparison with
other allocation strategies. Furthermore, our OEAS is extremely different from the currently
planned strategy. We suggest that our novel methodology be used to design optimal ARV
allocation strategies for resource-constrained countries.
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Open access, freely available online PLoS MEDICINEIntroduction
The HIV/AIDS epidemic is having a devastating impact in
sub-Saharan Africa and other resource-constrained regions.
Recently, the World Health Organization and other organ-
izations have committed to expand access to antiretrovirals
(ARVs) in the developing world, the United States govern-
ment has pledged to provide $15 billion for AIDS in Africa
and the Carribean, and drug prices have fallen [1]. However,
even if these resources are provided for the global treatment
of HIV, the number of individuals in need of treatment will
far exceed the supply of ARVs [1]. Thus, difﬁcult decisions
will have to be made as to how to design HIV treatment
strategies with these scarce resources. Resource allocation
decisions can be made on the basis of many different
epidemiological, ethical, or preferential treatment priority
criteria. Many diverse groups have been suggested for
treatment priority in resource-limited regions, including
the following: only men, pregnant women, children, the
sickest, the most economically productive, individuals in the
military, or even individuals of the dominant ethnic group
[2]. It has also been proposed that a lottery would be the only
fair approach to allocating ARVs [3]. Only a limited number
of ARVs will be available, and only a ﬁxed number of health-
care facilities (HCFs) can be used for ARV distribution. Thus,
the resource allocation decisions that need to be made are
extremely complex.
Here, we use operations research to address this important
resource allocation problem and to design ARV allocation
strategies that are rational and equitable. The allocation
decisions that we make here are based on ethical criteria, and
not on epidemiological or preferential treatment priority
criteria. Speciﬁcally, we determine the optimal allocation
strategy that would ensure that each individual with HIV has
an equal chance of receiving ARVs. We present a novel spatial
mathematical model of treatment accessibility that we use in
conjunction with an equity objective function to determine
an optimal equitable allocation strategy (OEAS) for ARVs in a
resource-constrained region. We quantify how changing the
size of the catchment region surrounding each HCF, and the
number of HCFs utilized for ARV distribution, alters the
OEAS. Speciﬁcally, we use data from the detailed ARV rollout
plan designed by the government of South Africa to
determine an OEAS (based upon a variety of assumptions)
for the province of KwaZulu–Natal. We also discuss how our
proposed ARV allocation strategy differs from the currently
proposed plan.
Our current analysis is applied to the South African
province of KwaZulu–Natal, although our methodology could
be applied to any resource-constrained setting. KwaZulu–
Natal is the largest province in South Africa with a
population of approximately 9.4 million and has more people
infected with HIV than any other province (approximately
21% of all cases in South Africa [4]). We use data from 51
communities (cities, towns, and villages) in the province of
KwaZulu–Natal; we exclude communities with a population
of less than 500 people. Data are not available on the number
of individuals with HIV in each speciﬁc community, and thus
we use the estimated HIV prevalence in the region
(approximately 13% in urban areas and 9% in rural areas
[4]) to estimate the number of infected people in each
community. See Figure 1 and Table 1 for the population sizes
and spatial locations of each of the 51 communities used in
our analysis. For our analysis the quantity of ARVs available
for distribution to the HCFs is sufﬁcient to treat 10% of the
total number of infected people, which is a realistic level
during the incremental scale-up of ARV therapy over the
next few years. The government of South Africa has selected
17 HCFs to participate in the ARV rollout that began in April
2004. These 17 HCFs are distributed throughout the province
(see Figure 1 and Table 2). Some communities are close to
HCFs, whilst others are a great distance from any HCF, with a
range of 0–90 km (Figure 2A). Hence, this spatial distribution
of HCFs produces large heterogeneity in accessibility to
treatment. Inequality in access to health care is a common
characteristic of resource-constrained regions [5,6,7,8,9,10].
We explicitly consider heterogeneity in treatment accessi-
bility in our analysis of ARV allocation strategies.
We have developed a novel spatial mathematical model of
treatment accessibility that we use to determine an OEAS for
ARVs in a resource-constrained region. To the best of our
knowledge, this is the ﬁrst analysis to address how to deal with
the extremely difﬁcult problem of allocating a scarce supply
of ARVs in order to design a rational and equitable allocation
strategy. We model the ‘‘spatial diffusion of treatment’’ to the
locations of disease, rather than modeling the ‘‘spatial
diffusion of disease,’’ which is the conventional approach
[11,12,13,14,15,16]. Our spatial model includes HCFs and the
HIV-infected communities surrounding these HCFs; we refer
to the region around each HCF as the catchment region.
Thus, the radius of the catchment region speciﬁes the
approximate maximum distance that we assume infected
people would be willing (or able) to travel for treatment. Each
HCF can serve many communities, and some communities
can access multiple HCFs; our model sums the number of
people with HIV in each HCF’s catchment region who could
potentially travel to the HCF to receive ARVs (we deﬁne this
number as the ‘‘effective demand’’ on that speciﬁc HCF).
Thus, the ‘‘effective demand’’ on each HCF is a direct
function of the number of individuals with HIV in the
catchment region, weighted by their distance from the HCF.
By including a weighting function we explicitly model
heterogeneity in accessibility to treatment based on distance
from the HCF. Here, the distance from a HCF becomes the
main determinant inﬂuencing whether or not an individual
with HIV has access to treatment.
We developed an equity objective function to assess how
the limited supply of ARVs should be allocated to each HCF
to ensure that an equal proportion of infected people in each
community receive treatment. To apply our theoretical
framework to KwaZulu–Natal we model the speciﬁc location
of the 17 HCFs and the 51 communities of 500 or more
individuals (see Figure 1); for these conditions we determine
an OEAS. We compared our OEAS with two other allocation
strategies: (i) allocating ARVs only to Durban, the major
urban area (i.e., concentrating ARVs where there is the best
health-care infrastructure) and (ii) allocating ARVs equally to
all 17 HCFs. We conduct our analysis assuming three
different radii of catchment regions: 20 km, 40 km, and 60
km. We then extend this analysis and recalculate the OEAS
assuming that more than 17 HCFs are available to distribute
ARVs. This analysis is useful because there is a second
potential pool of 27 ARV-implementation HCFs in the South
African operational plan for ARV rollout [17]. We analyze
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Equitable Treatment Allocation Strategiesthis case, in which 27 HCFs are utilized in the ARV rollout,
and we also analyze how optimal ARV allocation would
change if all 54 hospitals in KwaZulu–Natal were operational
for the rollout of ARVs.
Methods
Calculating Demand and Treatment Access
We assume that the number of people with HIV who will
travel to a speciﬁc HCF is directly proportional to the
number of individuals with HIV in that particular commun-
ity, but that the probability of an individual traveling to
receive ARVs (i.e., the treatment accessibility) decreases with
distance from the HCF. We deﬁne di,j as the distance from
community i to HCF j, f(di,j) as a weighting function that
determines the treatment accessibility to a HCF based upon
distance di,j, and Ii as the number of people with HIV in
community i. The distance, dij, between community i and HCF
j is based on the longitude (lon) and latitude (lat) of each
location and is determined by
dij ¼ RarccosðcosðlatiÞcosðlatjÞcosðlonj   loniÞ
þsinðlatiÞsinðlatjÞÞ; ð1Þ
where R is the radius of the earth, taken to be 6,371 km, and
the angles are in radian measure. We calculate the ‘‘effective
demand’’ of community i on HCF j to be the number of
people with HIV in community i that will travel to HCF j for
ARV regimes, namely, f(di,j)Ii. Thus, demand on HCFs for
ARVs is reduced by the treatment accessibility function. Our
model is conceptually similar to the ‘‘gravity’’ models that
have been used to predict retail travel [18], plan land use [19],
and determine accessibility of primary care [20]. However,
this is to our knowledge the ﬁrst time this approach has been
used to calculate ARV allocations. We use a Gaussian to
model treatment accessibility, f(d) = exp( kd
2), where k is a
dispersal length scale parameter determining the radius of
the catchment region. The size of the actual catchment
regions is unknown, but based upon distances from com-
munities to HCFs in KwaZulu–Natal (see Figure 2A) we
assume that individuals are likely to travel a maximum
distance of approximately 40 km to a HCF (k = 0.003786). We
vary the catchment region by considering a 20-km radius (k =
0.0151) and a 60-km radius (k = 0.00168). The different
catchment regions that we simulate (with radii of 20 km, 40
km, and 60 km) for each HCF are illustrated in Figure 2B–2D.
The number of people with HIV throughout the province
that have access to HCFs is approximately 86% of the total
number of people with HIV for the case of a 20-km
catchment region, 89% for a 40-km catchment region, and
93% for a 60-km catchment region.
Modeling the Distribution of Treatment
To determine how many ARVs should be allocated to each
HCF, we ﬁrst calculate how a given supply of ARVs will be
distributed from each HCF to the surrounding communities
in the catchment region. We calculate the ‘‘effective demand’’
on HCF j, Dj, to be
Dj ¼
X m
k¼1
fðdk;jÞIk; ð2Þ
which sums the ‘‘effective demand’’ of all communities on
HCF j (where there are m communities). Then, we model the
distribution of ARVs from a HCF to each community within
the catchment region as the proportion of the ‘‘effective
demand’’ on HCF j that is contributed by the respective
community. Accordingly, ARVs will be distributed from HCF,
j, to each community as the ratio
fðd1;jÞI1
Dj
:
fðd2;jÞI2
Dj
:...:
fðdm;jÞIm
Dj
: ð3Þ
Therefore, the number of people treated in community i by
the drug supply allocated to HCF j is
T
j
i ¼ Sj
fðdi;jÞIi
Dj
; ð4Þ
where Sj is the number of regimes allocated to HCF j. Hence,
the total number of people with HIV treated in community
i,Ti, summing over all n HCFs is
Ti ¼
X n
j¼1
T
j
i: ð5Þ
Figure 1. Map of South Africa Indicating the Location of the KwaZulu–Natal Province and Map of KwaZulu–Natal
Black crosses indicate the location of the 17 HCFs that have been designated for ARV rollout by the South African government, and the spatial
distribution of communities distinguished by the number of individuals infected with HIV (by both size and color). Durban (represented by the
large red diamond) is the capital city of the province and has more individuals with HIV than any other community. Pietermaritzburg and
Newcastle (represented by orange diamonds) have the next greatest numbers of individuals with HIV.
DOI: 10.1371/journal.pmed.0020050.g001
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Equitable Treatment Allocation StrategiesThe Equity Objective Function
We establish an equity objective function to determine the
optimal equitable allocation of ARVs to each HCF so that all
individuals with HIV have an equal chance of receiving
treatment. To obtain the same fraction of treated individuals
in each community, given that there are A ARV regimes for a
total of
Pm
k¼1 Ik individuals with HIV, the resulting objective
function to minimize (based on least squares) becomes
EðS1;S2;...;SnÞ¼
X m
i¼1
Ti
Ii
 
A
X m
k¼1
Ik
0
B B B @
1
C C C A
2
: ð6Þ
Our goal is to minimize E, by solving for the number of ARVs
to be allocated to each HCF (S1, S2,..., Sn), whilst enforcing
the following three constraints: (i) ensure that the total
number of ARVs available is equal to the sum of the supply
allocated to all HCFs,
A ¼
X n
j¼1
Sj; ð7Þ
(ii) ensure that only a positive number of ARVs are allocated
to each HCF (Sj   0, j =1 ...n); and (iii) ensure that the
number of people treated in each community is not greater
than the number of people with HIV in the community (Ti  
Ii,i=1 ...m). We note that if a different objective is required,
then all of our preceding analysis still holds and only the
functional form of the objective function needs to be altered.
To solve the problem, and determine the OEAS, we used
successive linear programming operations research techni-
ques [21].
Results
The OEAS of ARVs in KwaZulu–Natal that we determined
is complex (see Figure 3A and 3B). According to our OEAS,
the majority of ARVs should be allocated to HCFs in Durban,
Table 1. Communities in KwaZulu–Natal with Populations of at
Least 500 People
Place Population Latitude Longitude
Durban 2,531,300 29.878S 30.998E
Pietermaritzburg 457,700 29.618S 30.398E
Newcastle 309,400 27.758S 29.928E
Emnambithi 106,500 28.558S 29.788E
Epumalanga 97,700 29.828S 30.618E
Richards Bay 86,800 28.808S 32.098E
Vryheid 63,600 27.768S 30.798E
Esikhawini 39,300 28.888S 31.908E
Ladysmith 37,900 28.588S 29.888E
Stanger 36,700 29.348S 31.298E
Port Shepstone 34,700 30.728S 30.468E
Margate 34,100 30.858S 30.378E
Mondlo 33,900 27.988S 30.728E
Richmond 32,100 29.858S 30.298E
Wembezi 30,800 29.038S 29.828E
Dundee 29,800 28.168S 30.238E
Empangeni 29,500 28.748S 31.898E
Estcourt 25,800 28.998S 29.888E
Kokstad 25,100 30.558S 29.428E
Scottsburgh 23,700 30.288S 30.758E
Mpophomeni 21,100 29.568S 30.208E
Umkomaas 20,200 30.198S 30.808E
Howick 18,100 29.498S 30.228E
Ncotshane 17,800 27.388S 31.628E
Ballitoville 17,100 29.548S 31.208E
Ulundi 15,200 28.338S 31.418E
Eshowe 14,700 28.888S 31.468E
Sundumbili 14,600 29.138S 31.408E
Greytown 13,800 29.068S 30.598E
Glencoe 13,400 28.178S 30.158E
Mooi River 10,000 29.228S 29.998E
Paulpietersburg 8,500 27.428S 30.828E
Inyala 7,600 27.708S 29.968E
Ixopo 7,400 30.198S 30.358E
Ndumo 7,000 26.938S 32.258E
Mandeni 6,100 29.308S 31.258E
Matatiele 5,800 30.348S 28.838E
Dannhauser 5,000 28.038S 30.108E
Nongoma 4,600 27.768S 30.628E
Harding 3,900 30.588S 29.888E
Melmoth 3,800 28.588S 31.408E
Utrecht 3,500 27.668S 30.328E
Hluhluwe 3,200 28.028S 32.278E
Bergville 3,000 28.738S 29.378E
Nkandla 2,600 28.588S 31.698E
Kwambonambi 1,900 28.608S 32.108E
Impendle 1,500 29.568S 29.778E
Underberg 1,400 29.908S 29.428E
Wartburg 1,300 29.448S 30.578E
Nquthu 1,200 28.368S 30.808E
Kosi Bay 1,000 26.958S 32.828E
Camperdown 950 29.738S 30.538E
Creighton 500 30.038S 29.838E
Pongola 500 27.378S 31.618E
Mkuze 500 27.628S 32.038E
Hlomohlomo 500 27.728S 31.508E
The location and population of each community (city, town, or village) is indicated. Sources: [33] and the World
Gazetteer (http://www.world-gazetteer.com).
DOI: 10.1371/journal.pmed.0020050.t001
Table 2. HCFs Proposed for Use in the Rollout of ARVs in
KwaZulu–Natal
District Facility Name Latitude Longitude
eThekwini King Edward 29.878S 31.008E
RK Khan 29.928S 30.908E
Ugu Murchison 30.708S 30.338E
Port Shepstone 30.728S 30.468E
Umgungendlovu Edendale 29.618S 30.398E
Uthukela Ladysmith 28.588S 29.888E
Umzinyathi Dundee 28.168S 30.238E
Church of Scotland 28.738S 30.468E
Amajuba Newcastle 27.758S 29.928E
Madadeni 27.758S 30.038E
Zululand Nkonjeni 28.338S 31.418E
Umkhanyakude Mosvold 27.188S 32.258E
Mseleni 27.958S 33.478E
Uthungulu Ngwelezane 28.788S 31.788E
Empangeni 28.708S 31.858E
iLembe/King Shaka Stanger 29.348S 31.298E
Sisonke/East Griqualand Usher Memorial 30.558S 29.428E
Source: KwaZulu–Natal Department of Health (http://www.kznhealth.gov.za/default.htm).
DOI: 10.1371/journal.pmed.0020050.t002
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Equitable Treatment Allocation Strategiesand the remaining ARVs should be allocated to the other
HCFs throughout the province (with two non-Durban HCFs
receiving 5%–15% of the total ARVs and the remaining non-
Durban HCFs each receiving less than 5% of the total ARVs
available). We note that our OEAS does not produce perfect
equality; however, our optimal strategy signiﬁcantly improves
equality in obtaining treatment over the two other allocation
strategies that we analyzed for comparison: (i) ARVs allocated
only to one HCF (in the largest city, Durban) (see Figure 3D
and 3E), and (ii) equal quantities of ARVs allocated to each
HCF throughout the province (see Figure 3G and 3H). For
comparison of allocation strategies (in Figure 3) we used an
effective catchment radius of 40 km (k = 0.003786). The
proportion of infected individuals that are treated at each
location is displayed graphically in Figure 3 for our OEAS
(Figure 3C) and the two comparison allocation strategies
(Figure 3F and 3I). The best achievable outcome, given the
limited treatment resources available, is that 10% of people
with HIV are treated in each community throughout the
province, yielding the map shown in Figure 3C, 3F, and 3I,
but with dark blue/magenta over the entire province. Whilst
our OEAS does not fully achieve this, it is considerably better
than both of the comparison ARV allocation strategies.
Furthermore, the equity objective function evaluates to E =
0.27 for our OEAS, compared with (i) E = 0.50 and (ii) E =
133.88 for the comparison allocation strategies. There is large
Figure 2. Accessibility of Communities to HCFs
(A) A histogram indicating heterogeneity in the distance from communities in KwaZulu–Natal to the closest HCF. The treatment accessibility
function used in our model is a Gaussian distribution, exp( kd
2), indicating that accessibility is strongly related to distance (d), and k is a dispersal
length scale parameter.
(B) The catchment region is shown with an effective radius of 20 km for coverage from each HCF (k=0.0151).
(C) The catchment region is shown with an effective radius of 40 km for coverage from each HCF (k = 0.003786).
(D) The catchment region is shown with an effective radius of 60 km for coverage from each HCF (k = 0.00168).
In each case, the red dots indicate the location of the HCF, the green circles represent the locations where treatment accessibility has been
reduced to 50% relative to someone located at the HCF, and the blue circles represent the locations where treatment accessibility has been
reduced to 1% relative to someone located at the HCF. The locations of communities are presented as black diamonds. The large black
diamonds denote large communities (with population greater than 10,000 people), and the small black diamonds denote small communities
(with population less than 10,000 people). Substantially more area of the province is covered if HCFs have catchment regions of 60-km radius,
relative to catchment regions of 40-km radius, and substantially less area of the province is covered if HCFs have a catchment region of only 20-
km radius. However, the proportion of people with access does not differ greatly between the different catchment sizes because of the great
spatial heterogeneity in the prevalence of people with HIV.
DOI: 10.1371/journal.pmed.0020050.g002
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Equitable Treatment Allocation Strategiesdiversity in the fraction of individuals with HIV treated per
community when equal quantities of ARVs are given to each
HCF, evidenced by an inter-quartile range of 0.025%–
41.746% compared with inter-quartile ranges of 0%–0%
and 0.011%–9.982% for the ﬁrst comparison strategy and our
OEAS, respectively. Therefore, equal access is not obtained if
equal quantities of ARVs are allocated to each HCF.
Obviously, allocating to only one HCF (the ﬁrst comparison
strategy) could also be considered unequal because although
the inter-quartile range is minimal, effectively only one
community (Durban) receives ARVs. Our OEAS, while not
perfect, achieves the best equality possible given the
accessibility constraints and limited ARV supply.
The catchment region for HCFs is a factor of large
uncertainty. We considered three catchment region sizes:
radii of 20 km, 40 km, and 60 km. We also simulated two
additional cases with increased numbers and locations of
HCFs (27 HCFs as suggested in South Africa’s ofﬁcial ARV
rollout operational plan [17]; and all 54 hospitals in KwaZulu–
Natal). In Figure 4 we present box plots of the percentage of
Figure 3. Pie Charts of the Three Strategies for Allocating ARVs to HCFs
The three strategies considered are as follows: allocation of ARVs according to the results of minimizing our objective function (ﬁrst row)
allocation of ARVs only to one HCF in Durban (second row), allocation of ARVs equally to each of the 17 HCFs (third row). The proportion of
ARVs allocated by these strategies to the 17 different HCFs is indicated in (A), (D), and (G), with each HCF represented by a different color. The
spatial allocation of ARVs is shown in (B), (E), and (H), respectively. The respective percentage of infected people that are treated throughout the
KwaZulu–Natal province is simulated in (C), (F), and (I). Here, the x–y plane represents spatial location, and the shaded color at a location refers
to the proportion of individuals with HIV that are treated at the speciﬁed location. The plots were obtained by generating an interpolating
surface where the z-ordinate, colored by magnitude, represents the proportion of treated individuals, and then orientating the view of the
surface normal to the x–y plane. We performed surface data interpolation using the method of translates [32].
DOI: 10.1371/journal.pmed.0020050.g003
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Equitable Treatment Allocation Strategiesinfected people that obtain treatment per community for the
three sets of HCFs and the three catchment region sizes we
simulate. For each speciﬁed condition we calculate the OEAS.
It is apparent that equality in access to ARVs is improved
substantially if the radius of each catchment region is
increased and/or the number of HCFs is increased (Figure
4). Our results show that the number of HCFs utilized is of
greater importance than the size of the catchment region. If
54 HCFs are used, then even a (small) catchment radius of 20
km results in the ideal median proportion of 10% of people
with HIV in each community receiving ARVs. In the case of
27 HCFs, 88% of all people with HIV have access to HCFs for
a 20-km catchment region, 91% for a 40-km catchment
region, and 96% for a 60-km catchment region. In the case of
54 HCFs, 90% of all people with HIV in the province have
access to HCFs for a 20-km catchment region, 94% for a 40-
km catchment region, and 99% for a 60-km catchment
region. Therefore, increasing the number of HCFs available
for an ARV rollout is effective in signiﬁcantly increasing
equality in treatment accessibility as shown in Figure 4.
Furthermore, if catchment regions actually have a radius of
60 km, or can be increased to this size through improvements
in transportation, this would enable access to HCFs for
almost all people in the province, as shown in Figure 4. The
actual HCF allocations determined by our model and
optimization for the cases of 17, 27, and 54 HCFs (and for
all catchment sizes we consider) are presented as pie charts in
Figure 5. It is clear from our analysis that the equality
criterion, such that each individual with HIV in KwaZulu–
Natal has an equal chance of receiving ARVs, can best be
satisﬁed by utilizing all 54 HCFs for ARV distribution and
ensuring that each HCF serves a catchment region of 40 to 60
km.
Discussion
We have established an elegant and simple theoretical
framework for determining an equitable and rational
allocation of ARVs to HCFs in resource-constrained coun-
tries. To the best of our knowledge, this is the ﬁrst analysis to
address this very difﬁcult problem. We determined that
increasing the size of the catchment region of each HCF can
improve access to HCFs considerably for rural populations.
We suggest that studies be performed to collect data on the
distance that individuals with HIV are willing and able to
travel for treatment. This will facilitate discussions of this
important issue, which must be considered in the making of
policy decisions. A database consisting of such information
has been proposed for South Africa [22]. In an effort to
provide equal access to communities with relatively little
access to ARV therapy, the concept of a mobile clinic that
would travel between communities to take health-care work-
ers and resources to the location of the demand is a new
initiative in Nigeria (S. Agwale, personal communication) that
could also be considered in other regions.
We calculated the optimal allocation of ARVs to available
HCFs so that all infected individuals will have as close as
possible to an equal chance of obtaining treatment. We have
shown that increasing the number of HCFs involved in ARV
distribution can improve equality of access to ARVs
substantially. The current plan in KwaZulu–Natal is to use
only 17 HCFs. However, our results clearly show that in order
to achieve an optimal equitable allocation strategy, all
existing infrastructure (i.e., all 54 HCFs) should be used.
The strategy that we are advising may be fairly easy to
accomplish at the policy level because the health-care
infrastructure (speciﬁcally these HCFs) already exists,
although consideration must be made for issues such as the
training and transportation that is necessary, which may be
costly. In contrast, increasing the size of catchment regions
may be very difﬁcult. Obviously, increasing both the number
of HCFs and the size of the catchment region each services
would substantially increase equality of access to health care
in KwaZulu–Natal.
Future modeling studies could extend our work by not
making the simplifying assumption that all patients have
similar ease of travel over the same distance and by including
weighting functions on distance impedance for different
communities (based on the quality of the road infrastructure,
for example, and the availability of transportation) (D. P.
Wilson, J. O. Kahn, S. M. Blower, unpublished data). Here, we
have shown how to calculate optimal ARV allocation
strategies based upon the principle of equity. Future research
is necessary to compare ARV allocation strategies based upon
the principle of efﬁciency (i.e., allocating ARVs to maximize
epidemic reduction) in order to determine whether utilizing
different principles for optimization would result in similar
(or different) allocation strategies.
The World Health Organization and the Joint United
Nations Programme on HIV/AIDS have identiﬁed three core
principles that should underlie the effort to fairly distribute
ARVs, namely: urgency, equity, and sustainability [23]. They
Figure 4. Percentage of People with HIV That Obtain Treatment per
Community for Various Approaches
Box plots of the percentage of infected people that obtain treatment
per community for the three different sets of HCFs simulated in our
analysis for ARV rollout, namely, using the 17 HCFs likely to be used,
the 27 HCFs suggested by the South African government as potential
implementation points, and all of the 54 hospitals in the KwaZulu–
Natal province. These cases are represented for each of the three
catchment region sizes we considered (with radii of 20 km, 40 km, or
60 km) and referenced against the ideal fraction treated (dotted blue
line) under perfect conditions of egalitarian distribution, given the
limited ARV supply. The red crosses indicate the median percentage
of people with HIV that obtain treatment per community.
DOI: 10.1371/journal.pmed.0020050.g004
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Equitable Treatment Allocation Strategiesstate that policy decisions for the fair distribution of ARVs
should be based upon the following ethical principles: (i) the
principle that like cases should be treated alike, (ii) the
utilitarian principles of maximizing overall societal beneﬁts,
(iii) the egalitarian principles of equity (distributing resour-
ces, such as health care, equally among different groups), and
(iv) the Maximin principle (which prioritizes individuals that
are the least advantaged) [24]. Here, we investigated the level
of decision-making associated with allocating ARVs to HCFs,
and we have applied the egalitarian principle of equity with
respect to access to health care. We suggest that allocating
ARVs to HCFs to achieve equality in accessibility could be
carried out, and then individual-level ethical considerations
could be thought out at the next level of deliberation. Future
research is necessary to identify alternative (and more
detailed) ethical ARV allocation strategies.
Although we have focused on one equitable strategy, there
are many other ARV allocation strategies that are ethical.
Uneven access to HIV treatment has the very real potential to
fracture social and political structures and could lead to
intrastate and/or interstate conﬂict [2]. Government decisions
on ARV allocation have potentially socially destabilizing
ramiﬁcations because essentially the decisions determine who
lives and who dies. Resource allocation decisions will have to
be made at a number of levels: it must be decided what
proportion of the available ARVs should be allocated to each
province; then it must be decided how many ARVs should be
allocated to each HCF within each region; and ﬁnally,
particular groups of individuals may be chosen to have
treatment priority.
Treatment priority decisions for individuals could be based
on many different criteria, including disease progression
(CD4 cell counts and viral load), socioeconomic status,
ethnicity, and who is thought to have the greatest risk of
transmitting infections (for example, pregnant women with
HIV or female sex workers). Although it could be argued that
behavioral core groups should be targeted to receive ARVs
because this may have the greatest epidemiological impact,
such an allocation strategy would be neither feasible nor
practical to implement. For example, sex workers are an
obvious behavioral core group, but many women would likely
claim to be sex workers if they knew that ARVs were only
available to sex workers. Additionally, the ethics of targeting
such groups in favor of other societal groups must be
questioned. It could also be argued that, to maximize the
preventative effect of ARV therapy, ARVs should be
Figure 5. Actual Allocation of ARVs to HCFs
These pie charts show ARV allocation to HCFs according to our model and optimization for the cases of 17 , 27 , and 54. The allocation is shown
for each of the catchment region sizes considered: 20-km radius, 40-km radius, and 60-km radius.
DOI: 10.1371/journal.pmed.0020050.g005
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Equitable Treatment Allocation Strategiesconcentrated in virological core groups (i.e., people with the
highest viral load) [25,26]; this novel approach of targeting
the virological core group has recently been proposed for
controlling HSV-2 epidemics [27]. Identifying individuals in
the virological core group would be far easier than identify-
ing individuals in the behavioral core group. These individ-
uals are likely to be the sickest and those with evidence of
disease-related symptoms. Treatment allocation strategies
could also be designed based on reducing the future epidemic
impact and disregarding treatment equality amongst cur-
rently infected people. Such strategies place different social
value on currently infected people in comparison with future
infected people; such strategies therefore may not be ethical
even though they may be epidemiologically sound (also, it is
important to note that any epidemic predictions have large
uncertainty ranges [28,29]).
Our model has been applied to the South African province
of KwaZulu–Natal, but it can be applied by government
health ofﬁcials in any resource-constrained country. In many
of the countries worst affected by the HIV pandemic, scarcity
of resources will mean that not everyone that could
potentially beneﬁt from ARVs will be able to access them.
Many of the decisions that must be made to develop an
effective response to the HIV/AIDS epidemic are inevitably
underpinned by ethical considerations. Leadership in most
resource-constrained regions cannot avoid these decisions.
Whilst there has been considerable attention given to South
Africa, many other countries worldwide either have plans in
place (e.g., Brazil, Thailand, and Botswana) or are in the
process of developing national programs for ARV distribu-
tion through the public health system (e.g., Mozambique,
Malawi, and Kenya) [1]. Legitimate authorities in each nation
must come to their own consensus on the priorities and
objectives of an ARV rollout, which is not a trivial matter
[1,30]. Our objective function and model can be used to
calculate allocation strategies that provide equity in access
(compensating for geographical isolation), but if authorities
in a given nation prioritize a different goal for ARV rollout,
then an objective function to optimize can be formulated to
reﬂect the speciﬁc national policy goal. Our model can be
used by policy makers to determine an optimal scientiﬁcally
based allocation strategy, based upon the speciﬁc objective
function. As the ARV rollout commences in KwaZulu–Natal,
difﬁcult decisions will have to be made as to how to allocate
scarce resources. We have shown that it is possible to obtain a
mathematical solution to an equity problem. We suggest that
our novel approach could be used to determine optimal
equitable allocation strategies for many other resource-
constrained countries that are just beginning to receive
ARVs [31].
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Equitable Treatment Allocation StrategiesPatient Summary
Background Antiretroviral drugs can change the lives of patients with
HIV/AIDS. Their high price, however, means that many poor countries do
not have enough of these drugs to treat all the people who need them.
The decision of who will get treatment is very difficult, and different
ways to come up with ethical solutions to the problem have been
proposed.
Why Was This Study Done? One of the approaches is to try to make
sure that every infected person has the same chance to get antiretroviral
drugs. David Wilson and Sally Blower, the authors of this study, wanted
to find a scientific strategy to achieve this goal of equal access.
What Did the Researchers Do? They used mathematical models to
calculate how to distribute available drugs among hospitals and doctor’s
offices so that each patient in a particular area had an equal chance to
get treated.
What Did They Find? When they used their approach on a real example,
the South African province of KwaZulu–Natal, they found that making
some changes to the current plans for drug distribution would lead to
more equal access among all of the individuals with HIV in the province.
Instead of only 17 out of the 54 health care facilities in KwaZulu–Natal
distributing the drugs (which is the current plan of the South African
government), Wilson and Blower calculate that it would be fairer if all 54
facilities distributed the medicines.
What Does This Mean? Mathematical models like the one used here are
always based on assumptions and simplifications. As a consequence,
they are never perfect matches for a real-life situation, but they can help
to guide complicated decisions. This article suggests that the approach
Wilson and Blower developed could help to determine strategies for
equitable allocation of limited HIV treatment resources.
What Next? The authors hope that the tools they developed will be
used by policy makers in resource-poor countries to guide their
strategies. They are keen to work with these policy makers to adapt
and optimize the method to local settings and priorities.
More Information Online Report by the World Health Organization and
the Joint United Nations Programme on HIV/AIDS on ethics and
equitable access to HIV/AIDS treatment: http://www.who.int/hiv/pub/
advocacy/en/ethicsmeetingreport_e.pdf
Ruth Macklin’s report on ethics and equity in access to HIV treatment:
http://www.who.int/ethics/en/background-macklin.pdf
The Pro-Poor Health Policy Team’s report on priority in HIV/AIDS
treatment: http://www.who.int/ethics/en/background-pro-poor3.pdf
News article from the World Health Organization Bulletin on the South
African HIV/AIDS treatment program: http://www.who.int/bulletin/
volumes/82/1/en/news.pdf
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